Search Result "pemetrexed erlotinib gefitinib"
Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 11 Issue: 1 Year: 2010 Page: 85-94
Author(s): Tianhong Li, Primo N. Lara Jr., Philip C. Mack, Roman Perez-Soler, David R. Gandara, Gert van Assche, Severine Vermeire, Paul Rutgeerts
The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features
Journal: Current Drug Targets
Volume: 11 Issue: 1 Year: 2010 Page: 74-77
Author(s): Michael Duruisseaux, Jacques Cadranel, Maurice Perol, Dominique Arpin
The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 11 Issue: 1 Year: 2010 Page: 2-11
Author(s): Krzysztof Konopa, Jacek Jassem
Modulation of Signaling Enhances the Efficacy of the Combination of Satraplatin and Erlotinib
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1312-1321
Author(s): Abolfazl Avan,Auke D. Adema,Eveline K. Hoebe,Charlotte M. Huijts,Amir Avan,Gareth J. Veal,Rob Ruijtenbeek,Katja Wosikowski,Godefridus J. Peters
The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 11 Issue: 1 Year: 2010 Page: 58-60
Author(s): Steven Tucker
Factors Driving the Choice of the Best Second-Line Treatment of Advanced NSCLC
Journal: Reviews on Recent Clinical Trials
Volume: 6 Issue: 1 Year: 2011 Page: 44-51
Author(s): Paolo Maione, Antonio Rossi, Maria Anna Bareschino, Paola Claudia Sacco, Clorinda Schettino, Marzia Falanga, Valentina Barbato, Rita Ambrosio, Cesare Gridelli
Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Journal: Current Drug Targets
Volume: 11 Issue: 1 Year: 2010 Page: 12-28
Author(s): Elisa Giovannetti, Richard Honeywell, Axel R. Hanauske, Christina Tekle, Bart Kuenen, Jennifer Sigmond, Giuseppe Giaccone, Godefridus J. Peters
Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 176-191
Author(s): R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio, M. Casto
Methodological Issues of Clinical Research with EGFR Inhibitors
Journal: Current Cancer Therapy Reviews
Volume: 3 Issue: 4 Year: 2007 Page: 292-302
Author(s): Alessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, Fabiano Falasconi, Nicola Normanno, Francesco Perrone
Novel Compounds and Drugs and Related Patents in Lung Cancer Chemotherapy
Ebook: Topics in Anti-Cancer Research
Volume: 4 Year: 2015
Author(s): Attapon Cheepsattayakorn,Ruangrong Cheepsattayakorn
Doi: 10.2174/9781681080765115040014